Week Ahead: Nike, Constellation Brands, General Mills

Week Ahead: Nike, Constellation Brands, General Mills

Earnings are in focus with Nike, Constellation Brands, and General Mills reporting in the coming days. Bloomberg's Nathan Hager previews the numbers with Kristine Aquino, Bloomberg Managing Editor for Markets Live. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Onsemi, Oracle End Week Lower, Biotechne Jumps

On this episode of Stock Movers: - Onsemi (ON) shares ended the week lower following news the US chipmaker has agreed to buy Synaptics Inc., a firm that specializes in semiconductors for smart devices. - Bio-Techne (TECH) shares ended the week higher after Merck agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade. - Oracle (ORCL) stock plummeted this week as concerns mount over the company's debt-load and following the news reported by the New York Times that OpenAI could delay its IPO until next year. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Banks Slide on OpenAI IPO Warning, Onsemi, Darden Lower

On this episode of Stock Movers: - Shares of Goldman Sachs (GS) slide after the New York Times reported that bankers advising OpenAI cautioned that volatility in tech stocks could dent enthusiasm for an offering. - Onsemi (ON) shares slide following news the US chipmaker has agreed to buy Synaptics Inc., a firm that specializes in semiconductors for smart devices. - Darden Restaurants (DRI) dips slightly after the restaurant chain operator reported worse-than-expected sales performance for Olive Garden, while the LongHorn’s unit topped the Street view. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Strategy Mixed, Netflix Rises, Moderna Rises After Price target Raised

On this episode of Stock Movers: - Strategy (MSTR) shares are mixed. On Friday, Billionaire Michael Saylor on Friday defended Strategy’s approach to Bitcoin. - Netflix (NFLX) shares rise. Investors weigh the company’s push into live sports despite a thinning slate of mega-hit series. - Moderna (MRNA) shares rise. Piper Sandler raised the firm's price target on Moderna to $77 from $69 and keeps an Overweight rating on the shares. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Synaptics Rises, Lumentum Falls, Acadia Pharma Jumps on Positive CHMP Drug Opinion

On this episode of Stock Movers: Synaptics (SYNA) shares rise. Onsemi has agreed to buy Synaptics Inc. in an all-stock deal that values the company at about $6.2 billion. The transaction has a total enterprise value including debt of roughly $7 billion and is expected to close in mid-2027, subject to approvals. Lumentum (LITE) shares fall. U.S. optical communication stocks dropped. This comes as Semiconductor stocks are broadly lower. Acadia Pharma (ACAD) shares climb as much as 12%, the most intraday since May 2025, after the drugmaker said the European Medicines Agency’s CHMP issued a positive opinion for its drug to treat symptoms of Rett syndrome and recommended granting a marketing authorization. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.